ROCK1 overexpression has been linked to AML cell lines and overall survival of AML patients, suggesting that ROCK inhibition may mediate leukemic cell death and improve conventional AML therapeutics (Figures S1 and S2). The gene discussed is ROCK1; the disease is acute myeloid leukemia.